Procedure Volume Growth
System Placements
The company placed 532 da Vinci systems in Q4 2025, up from 493 in Q4 2024. Of these, 303 were da Vinci 5 systems, versus 174 prior year. Full-year placements reached 1,721 systems, including 870 da Vinci 5, compared to 1,526 total in 2024. Ion placements fell to 42 in Q4 from 69, and 195 for the year from 271. Operating leases included 250 da Vinci systems in Q4, with 150 usage-based.
Revenue Breakdown
Preliminary Q4 revenue hit $2.87 billion, up 19% from $2.41 billion. Instruments and accessories revenue grew 17% to $1.66 billion. Systems revenue reached $786 million, up from $655 million. Full-year revenue was $10.06 billion, a 21% increase from $8.35 billion. Instruments and accessories rose 19% to $6.02 billion. Systems revenue increased to $2.47 billion from $1.97 billion. Average da Vinci utilization rose 4%.
Other Highlights
Q4 expenses included a $70 million Intuitive Foundation contribution, up from $45 million. Results remain preliminary pending final audit. CEO Dave Rosa noted strong adoption of surgical platforms and over 3.1 million da Vinci procedures.
About
Intuitive Surgical, based in Sunnyvale, California, leads in minimally invasive care and pioneered robotic-assisted surgery. Its technologies include da Vinci surgical systems and the Ion endoluminal system, combining advanced tools, learning programs, and services to optimize physician care delivery and patient outcomes. The company envisions less invasive care that detects diseases early for faster recovery.